Performance of basal follicle-stimulating hormone and patient's age in the prediction of poor ovarian response and IVF outcome of women who developed.

Slides:



Advertisements
Similar presentations
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Advertisements

Age at menarche: a predictor of diminished ovarian function?
Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D
The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated.
Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc
Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M
James P Toner, M.D., Ph.D.  Fertility and Sterility 
Patient-tailored ovarian stimulation for in vitro fertilization
Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women  Carlos Iglesias, M.D., Manish Banker, M.D.,
Combining cycle day 7 follicle count with the basal antral follicle count improves the prediction of ovarian response  Fatih Durmusoglu, M.D., Koray Elter,
Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained.
The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count  Simone L. Broer, B.Sc., Ben Willem J.
Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D
Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
D.H. Williams, S.A. Land, M. Han, P.D. Sutton, R.E. Brannigan 
A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data 
Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.
Assisted reproductive technology in the United States: 2000 results generated from the American Society for Reproductive Medicine/Society for Assisted.
Do anti-mullerian hormone levels predict ovarian reserve in SLE patients presenting for hematopoietic stem cell transplant?  H. Browne, A. Armstrong,
Deleterious effect of tobacco on IVF outcome and ovarian reserve as reflected by serum anti mullerian hormone (AMH)  P. Barriere, T. Freour, D. Masson,
Dynamic antimüllerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes  Aaron.
A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization  Laura Detti, M.D., Daniel B. Williams, M.D., Jared.
Improved implantation and pregnancy rates in donor recipients using transdermal hormone replacement therapy  A. Criniti, G. Chow, L. Craig, A. Khabani,
Clinical Assessment of Recombinant Human Follicle-Stimulating Hormone in Stimulating Ovarian Follicular Development Before In Vitro Fertilization fn1 
David E. Reichman, M.D., Dan Goldschlag, M.D., Zev Rosenwaks, M.D. 
Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation  Nam D. Tran, M.D., Ph.D., Lusine Aghajanova, M.D.,
Fertility and Sterility
Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis.
Ovarian hyperstimulation secondary to ectopic secretion of follicle-stimulating hormone. Literature review prompted by a case  Jorge Burgos, M.D., Patricia.
Treatment of Ovarian Hyperstimulation Syndrome Utilizing a Dopamine Agonist and Gonadotropin Releasing Hormone antagonist  N. Rollene, M. Amols, S. Hudson,
Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro.
Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis  Rina Agrawal,
Birth outcomes after spontaneous or assisted conception among infertile Australian women aged 28 to 36 years: a prospective, population-based study  Danielle.
A. Criniti, G. Chow, A. Khabani, L. Scott, N.A. Klein 
Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization outcome in.
Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening  Tarun Jain, M.D., Michael.
Fertility and Sterility
A retrospective study on the use of dose-dependent letrozole to decrease cancer recurrence and adverse events in patients undergoing ovarian stimulation 
P-425 Fertility and Sterility Volume 86, Issue 3, (September 2006)
A double-blind clinical trial comparing a fixed daily dose of 150 and 250 IU of recombinant follicle-stimulating hormone in women undergoing in vitro.
Complex chromosome abnormality in patients with in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI)  S.P. Weng, T.C.J. Wu, S.P. Kang,
Stephanie A. Beall, M.D., Ph.D., Alan DeCherney, M.D. 
Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis.
The Routine use of Follitropin Alfa (FbM) Pre-Filled Pen for Follicular Development for IVF. A Large Multinational Observational Study in Northern Europe 
Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify.
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Increased total and phosphorylated glycogen synthase kinase-3 (GSK-3) in the adipocytes of patients with the polycystic ovary syndrome (PCOS)  W.Y. Chang,
Cumulative ovulation and pregnancy rates according to recombinant human follicle stimulating hormone (r-hFSH) dosing: Comparison of a new formulation.
Current evaluation of amenorrhea
A woman with premature ovarian failure induced by Tripterygium wilfordii Hook.f. gives birth to a healthy child  Xin Chen, M.D., M.Sc., Shi-ling Chen,
Fertility and Sterility
A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human.
Fertility and Sterility
Serum anti-Mullerian hormone dynamics during stimulated cycles by aromatase inhibitor anastrozole and clomiphene citrate in women with infertility  H.-H.
Comparison of the Ovulation Induction and Hormone Profile Between Anastrozole and Clomiphene Citrate in Women With Infertility  H. Wu, P. Chen, N.M. Wang,
Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function  David H. Barad, M.D., M.S., Andrea Weghofer,
Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories  Melissa C. Yih, M.D.,
Cem Fiçicioǧlu, M. D. , Tayfun Kutlu, M. D. , Elif Baglam, M. D
Fertility and Sterility
Multiple fertility preservation approach in cancer patients: IVF and embryo freezing using donor or husband sperm combined with oocyte cryopreservation.
Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles 
B.J. Deenihan, G.D. Ball, B.L. Tjaden, D.A. Grainger 
Treatment decision trends in the infertility patient journey from 78,958 cycles in a real- world database: impact of age, diagnosis, and year of treatment 
Conversion from assisted reproductive technology to intrauterine insemination in low responders: Is it advantageous?  John M. Norian, M.D., Eric D. Levens,
A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders  Hakan Cakmak, M.D., Nam D. Tran,
Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles2 
A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three- dimensional ultrasound determinants of ovarian reserve in the prediction.
Comparisons of inhibin B versus antimüllerian hormone in poor ovarian responders undergoing in vitro fertilization  Rongrong Tan, M.M.Sc., Danhua Pu,
The cumulative probability of liveborn multiples after in vitro fertilization: a cohort study of more than 10,000 women  Beth A. Malizia, M.D., Laura.
Presentation transcript:

Performance of basal follicle-stimulating hormone and patient's age in the prediction of poor ovarian response and IVF outcome of women who developed less than 5 follicles  D. Aslan, I. Aruh, F. Karaarslan, T. Pinar, R. Keles, N. Demir  Fertility and Sterility  Volume 82, (September 2004) DOI: 10.1016/j.fertnstert.2004.07.553 Copyright © 2004 Terms and Conditions

Fertility and Sterility 2004 82, DOI: (10.1016/j.fertnstert.2004.07.553) Copyright © 2004 Terms and Conditions

Fertility and Sterility 2004 82, DOI: (10.1016/j.fertnstert.2004.07.553) Copyright © 2004 Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.